THE INFL UENCE OF PLACENTAL DRUG LAENNEC ON MOTOR FUNCTION OF THE BILIARY TRACT IN PATIENTS WITH FATTY DEGENERATION OF LIVER
Abstract
Non-alcoholic fatty liver disease (NAFLD) is one of the most urgent problems of modern medicine - is the subject of numerous studies, causing interest of different medical specialists This paper presents our own experience of supervision of patients with fatty degeneration of liver on the background of the application of human placenta extract - Laennec. We treated 11 patients with fatty degeneration of the liver and examined the motor-evacuation function of the hepatobiliary tract before and after treatment. The control group consisted of 50 healthy subject aged between 19 to 21 years. Laennec was administered intramuscularly to 2 ml a day, a course of 20 injections. Usage of placental drug Laennec has a stimulating influence on the processes of choleresis and bile secretion in patients with fatty degeneration of the liver, and normalizes the motility of the sphincter and contractility of the gall bladder
About the Authors
V. A. Maksimov
MNTO, “Granit“
Russian Federation
Russian Federation
E. S. Buntin
Penza oblast clinical hospital named N. N. Burdenko
Russian Federation
Russian Federation
B. G. Buntina
Penza oblast clinical hospital named N. N. Burdenko
Russian Federation
Russian Federation
E. E. Mysenkova
Penza oblast clinical hospital named N. N. Burdenko
Russian Federation
Russian Federation
K. N. Samartsev
Penza oblast clinical hospital named N. N. Burdenko
Russian Federation
Russian Federation
G. V. Vostokovf
Penza oblast clinical hospital named N. N. Burdenko
Russian Federation
Russian Federation
References
1. Лонд Э. Р., Эльштейн Н. В., Мардна У. Б. и др. Диагностика в связи с диспансеризацией больных хроническими заболеваниями желчевыводящих путей.// Актуальные вопросы гастроэнтерологии. Тез. докл. II съезда гастроэнтерологов УССР. - Днепропетровск,1989. - С. 35-36.
2. Максимов В. А., Галкин В. А. - Значение методики определения часовой секреции печёночной желчи. // Врач.дело,1977. -№ 2. - С. 107-108.
3. Максимов В. А., Чернышёв А. Л., Тарасов К. М. Дуоденальное исследование - М.: Медицинская газета, серия «интеллектуальноёмкие технологии» вып.9, - 1998. -191 с
4. Шварц В., Ногаллер А. М. Неалкогольный стеатогепатит//Врач.,2011. -№ 10.
5. Adams LA, Lymp JF, St. Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a populationbased cohort study. Gastroenterology. 2005; 129: 113-21
6. Brea A, Mosquera D, Martin E, et al. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: A case-control study. Arterioscler Thromb Vasc Biol. 2005; 25: 1045-50.
7. De Alwis NM, Day CP. Nonalcoholic fatty liver disease: the mist gradually clears. J Hepatol. 2008; 48 (suppl. 1): 104-12.
8. Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evalution and management. Hepatology. 2009; 49:306-17.
Review
For citations:
Maksimov V.A., Buntin E.S., Buntina B.G., Mysenkova E.E., Samartsev K.N., Vostokovf G.V. THE INFL UENCE OF PLACENTAL DRUG LAENNEC ON MOTOR FUNCTION OF THE BILIARY TRACT IN PATIENTS WITH FATTY DEGENERATION OF LIVER. Experimental and Clinical Gastroenterology. 2016;(11):100-103. (In Russ.)
Views:
225
Email this article 